GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,618.00p
   
  • Change Today:
    -15.50p
  • 52 Week High: 1,722.50
  • 52 Week Low: 1,387.50
  • Currency: UK Pounds
  • Shares Issued: 4,917.43m
  • Volume: 6,307,417
  • Market Cap: 79,564m
  • RiskGrade: 73
  • Beta: 1.08

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.9% 5.2%
Div Cover 1.3 1.4
Op Mrgn 9.3% 25.5%
ROCE 162.9%  
Latest F'cast
P/E 15.8 14.8
PEG 0.4 2.0
Pr/Revenue 2.9 2.7
Pr/Book 16.0  
Latest F'cast
Revenue 16.6% 7.6%
PBT -81.6% 294.5%
EPS 35.3% 7.5%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 26,431.00 6,600.00 111.40p 12.0 n/a -2% 74.00p 5.5%
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 30,014.35 7,649.14 110.09p 14.7 2.0 +8% 80.00p 5.2%
31-Dec-18 31,061.96 8,070.98 114.10p 14.2 3.9 +4% 80.09p 5.2%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 22-May-2017 16:45 RNS
Director/PDMR Shareholding 22-May-2017 16:40 RNS
Ph3 MUSCA study presented at ATS 22-May-2017 14:23 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
10-May-17 Transfer From Simon Dingemans 0.000p 8 0.00
10-May-17 Transfer From Victoria Whyte 0.000p 8 0.00
10-May-17 Buy Patrick Vallance 1,614.73p 7 113.03

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,618.00p
Change Today -15.50p
% Change -0.95 %
52 Week High 1,722.50
52 Week Low 1,387.50
Volume 6,307,417
Shares Issued 4,917.43m
Market Cap 79,564m
Beta 1.08
RiskGrade 73

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.56% above the market average9.56% above the market average9.56% above the market average9.56% above the market average9.56% above the market average
89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average
Price Trend
18.62% above the market average18.62% above the market average18.62% above the market average18.62% above the market average18.62% above the market average
19.35% above the sector average19.35% above the sector average19.35% above the sector average19.35% above the sector average19.35% above the sector average
Income
75.26% above the market average75.26% above the market average75.26% above the market average75.26% above the market average75.26% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Growth
9.00% above the market average9.00% above the market average9.00% above the market average9.00% above the market average9.00% above the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average

What The Brokers Say

Strong Buy 14
Buy 1
Neutral 13
Sell 0
Strong Sell 2
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  1st Interim Q4
Ex-Div 11-May-17 23-Feb-17
Paid 13-Jul-17 13-Apr-17
Amount 19.00p 23.00p

Trades for 25-May-2017

Time Volume / Share Price
17:04 2,713 @ 1,618.56p
17:04 24,540 @ 1,619.44p
17:04 9,276 @ 1,619.44p
17:04 3,852 @ 1,625.78p
17:04 5,767 @ 1,619.44p

GlaxoSmithKline Key Personnel

Chair Moncef Slaoui
CFO Simon Dingemans
CEO Emma Walmsley

Top of Page